KRISTINA JOHNSON: Open Payments
NPI 1932869286 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$641 in 22 payments from 11 companies in 2025. Trend: 2023 $104 · 2024 $661 · 2025 $641
Food & beverage: $641
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $251 |
| GlaxoSmithKline, LLC. | 3 | $75 |
| Novo Nordisk Inc | 3 | $67 |
| Amgen Inc. | 2 | $48 |
| ABBVIE INC. | 2 | $47 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $21 |
Products named: BREZTRI, TRELEGY ELLIPTA, AIRSUPRA, EVENITY, UBRELVY, Symbravo, UZEDY, Rybelsus.
Industry payments across CA — which companies pay providers there.
